Effects of Hormone Replacement Therapy on Women's Lung Health and Disease.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 461, doi. 10.1007/s41030-023-00240-0
- By:
- Publication type:
- Article
Works matching IS 23641746 AND DT 2023 AND VI 9 AND IP 4
Results: 5
1
2
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 479, doi. 10.1007/s41030-023-00241-z
- By:
- Publication type:
- Article
3
Cradle-to-Grave Emission Reduction for Easyhaler Dry Powder Inhaler Product Portfolio.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 527, doi. 10.1007/s41030-023-00239-7
- By:
- Publication type:
- Article
4
Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 511, doi. 10.1007/s41030-023-00244-w
- By:
- Publication type:
- Article
5
Associations of Awake Prone Positioning-Induced Changes in Physiology with Intubation: An International Prospective Observational Study in Patients with Acute Hypoxemic Respiratory Failure Related to COVID-19.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 499, doi. 10.1007/s41030-023-00242-y
- By:
- Publication type:
- Article